Biotage AB (publ) (BITGF)
USD 11.5
(31.13%)
USD 11.5
(31.13%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 126.33 Million USD | 88.45% |
| 2022 | 67.04 Million USD | -1.95% |
| 2021 | 68.37 Million USD | 26.35% |
| 2020 | 54.11 Million USD | 10.08% |
| 2019 | 49.15 Million USD | 44.79% |
| 2018 | 33.95 Million USD | 87.09% |
| 2017 | 18.14 Million USD | 24.94% |
| 2016 | 14.52 Million USD | 0.23% |
| 2015 | 14.49 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 1.05 Billion USD | 964.96% |
| 2024 Q2 | 99.06 Million USD | -15.69% |
| 2024 Q1 | 117.49 Million USD | -6.56% |
| 2023 FY | 125.74 Million USD | 87.56% |
| 2023 Q3 | 119.56 Million USD | 3.14% |
| 2023 Q2 | 115.92 Million USD | 79.62% |
| 2023 Q4 | 125.74 Million USD | 5.17% |
| 2023 Q1 | 64.54 Million USD | -3.73% |
| 2022 Q2 | 65.93 Million USD | 3.31% |
| 2022 FY | 67.04 Million USD | -1.95% |
| 2022 Q4 | 67.04 Million USD | 5.71% |
| 2022 Q3 | 63.41 Million USD | -3.82% |
| 2022 Q1 | 63.82 Million USD | -6.65% |
| 2021 Q1 | 56.61 Million USD | 0.0% |
| 2021 Q4 | 68.37 Million USD | 45.47% |
| 2021 Q3 | 46.99 Million USD | 3.03% |
| 2021 Q2 | 45.61 Million USD | -19.43% |
| 2021 FY | 68.37 Million USD | 26.35% |
| 2020 FY | 54.11 Million USD | 10.08% |
| 2019 FY | 49.15 Million USD | 44.79% |
| 2018 FY | 33.95 Million USD | 87.09% |
| 2017 FY | 18.14 Million USD | 24.94% |
| 2016 FY | 14.52 Million USD | 0.23% |
| 2015 FY | 14.49 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | -5276.431% |
| Ansell Limited | 1.32 Billion USD | 90.5% |
| Ansell Limited | 1.33 Billion USD | 90.518% |
| BG Medicine, Inc. | - USD | -Infinity% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -13294.985% |
| Psykey, Inc. | 2.47 Million USD | -5006.58% |
| ConvaTec Group Plc | 2.01 Billion USD | 93.74% |
| ConvaTec Group Plc | 2.02 Billion USD | 93.749% |
| Encision Inc. | 1.98 Million USD | -6267.933% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | -4055.192% |
| Innovative MedTech Inc. | 6.13 Million USD | -1959.348% |
| LifePoint, Inc. | 2.45 Million USD | -5047.883% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | -1140.917% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | -3615.816% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | -4055.406% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -16173.739% |
| SmileDirectClub, Inc. | 982.26 Million USD | 87.138% |
| Sector 10, Inc. | 9.84 Million USD | -1183.212% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | 90.681% |
| SheerVision, Inc. | 1.43 Million USD | -8726.148% |
| United Health Products, Inc. | 1.99 Million USD | -6220.462% |
| Vasamed, Inc. | 1 Million USD | -12467.169% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | -3224.428% |
| Yubo International Biotech Limited | 2.91 Million USD | -4235.657% |